Related Experiment Video
Updated: May 2, 2026
12:47
Inducing Plasticity of Astrocytic Receptors by Manipulation of Neuronal Firing Rates
Published on: March 20, 2014
14.3K
A molecular switch for neuroprotective astrocyte reactivity
Evan G Cameron1, Michael Nahmou2, Anna B Toth2
1Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA. egcamer1@gmail.com.
Nature
|December 12, 2023
Summary
This study reveals cyclic adenosine monophosphate (cAMP) as a key regulator of astrocyte responses after optic nerve injury. Manipulating cAMP levels can shift astrocytes towards neuroprotection, promoting retinal ganglion cell survival.
Area of Science:
- Neuroscience
- Cell Biology
- Ophthalmology
Background:
- Mechanisms controlling neurotoxic vs. neuroprotective astrocyte phenotypes are unclear.
- Reactive astrocytes, previously A1/A2, comprise distinct subpopulations.
- Understanding astrocyte roles is crucial for CNS repair and treating optic neuropathies.
Purpose of the Study:
- Investigate intrinsic mechanisms regulating astrocyte phenotypes.
- Identify molecular switches controlling astrocyte reactivity and outcomes.
- Develop therapeutic strategies for optic nerve injury and glaucoma.
Main Methods:
- Analysis of astrocyte differentiation markers (C3) and gene expression.
- Investigated cyclic adenosine monophosphate (cAMP) regulation by soluble adenylyl cyclase.
- Utilized a viral vector to target optic nerve head astrocytes in vivo.
- Assessed microglial activation and retinal ganglion cell survival post-injury.
Main Results:
- Injured astrocytes form distinct C3+ (neurotoxic) and C3- (neuroprotective) subtypes.
- Compartmented cAMP, regulated by soluble adenylyl cyclase, balances astrocyte phenotypes.
- Proliferating neuroprotective astrocytes suppress microglial activation and neurotoxic astrocyte differentiation.
- Targeting cAMP in reactive astrocytes promotes RGC survival and inhibits detrimental immune cell activation.
Conclusions:
- Soluble adenylyl cyclase and compartmentalized cAMP act as a molecular switch for neuroprotective astrocyte reactivity.
- Targeting cAMP pathways offers a therapeutic strategy for optic neuropathies.
- New reactive astrocyte subtypes and therapeutic targets are identified for glaucoma and optic nerve injury treatment.
